Cite
HARVARD Citation
Galluzzo, M. et al. (2023). Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks. Expert opinion on biological therapy. pp. 371-381. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Galluzzo, M. et al. (2023). Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks. Expert opinion on biological therapy. pp. 371-381. [Online].